Investment
Capital to fund manufacturing, tooling, FDA registration, and go-to-market for both product lines.
For investors & partners
A clinician-built technology entering a market with no moldable competitor
Working prototypes of both devices exist today. A US provisional patent is filed, the regulatory path is a Class I registration, and prior patents in the space have lapsed. What EarArmor needs now is capital and commercialization expertise, and that's why this page exists.
Stage
Prototype finalization; clinical use in founder's practice
Intellectual property
US provisional patent application filed
Regulatory
FDA Class I registration~$30K · ~1 month
Backing
Funding support by Foundation Venture Capital Group
The thesis
The case for EarArmor
-
01
Clinician-driven design
Invented by the ENT surgeon who treats auricular hematoma regularly in his practice, refined with Merge Medical Device Studio, and already used successfully on multiple patients in clinic. The design answers real clinical failure modes, not a market survey.
-
02
Open competitive ground
Every prior patent in the space is withdrawn or inactive. Current competitors sell rigid discs that cannot mold to ear contours. No ear plug on the market combines custom molding, water protection, and magnetic retention.
-
03
Platform economics
One material system, moldable EVA plus magnets, yields multiple products across treatment, prevention, and comfort, sold direct to providers and direct to consumers. A low-cost Class I pathway keeps time-to-market short.
Market opportunity
4.38 million addressable patients for the hematoma system
Auricular hematoma risk concentrates in contact-sport athletes competing at high school varsity level and above: an estimated 20% of each population below. Girls' high school wrestling, the fastest-growing sport in the US, is expanding the market each season.
Addressable patients by sport
- Addressable (est. 20%)
- Rest of total population
96%of Finnish martial artists have experienced an auricular hematoma, in studies
55.5%of high-level judo practitioners have experienced one
Serviceable available market
$262.8–525.6M
4.38M patients at $60 (affordable) to $120 (premium) per mold.
Serviceable obtainable market
$78.6–157.7M
30% market share across US and Europe, 1.31M cases.
The second market
Ear tube placement is the most common surgery in the US: 700,000 procedures a year, each one a family needing reliable, child-sized water protection. Professionally molded plugs run $75–$500 per ear and are outgrown in a season. Our plug molds at home for a fraction of that.
Competitive landscape
Existing products are rigid discs that cannot mold to the ear
| Product | Price | Limitation |
|---|---|---|
| EarSplintz | $112 | Mold kit with base and catalyst; multi-step preparation, head wrap required |
| CauliBuds | $44.95 | Rigid disc-shaped magnets in two fixed sizes |
| MagnetRx | $34.95 | Assorted rigid magnets with rubber spacers, no molding |
| Earies | $29.95 | Single set of rigid disc magnets on a strap |
| Earlox | $35.99 | Rigid disc magnets in two fixed sizes |
| EarArmor | $60–120 | Fully moldable to individual ear contours: uniform pressure, restores pre-injury form |
In the ear plug category: silicone plugs are single-use and can break off in the canal; foam offers no water protection; Decibullz molds but is sound-only with no retention system; SurfEars is water-only and neither moldable nor magnetically attached.
Where we are
Where the company stands today
EarArmor is early-stage, and we present it that way. The technical risk is largely behind us; the work ahead is production, registration, and distribution, which is exactly where the right partners change the slope of the curve.
Exit strategy
License of the technology, or acquisition of the startup after initial sales, by an active market participant.
-
Concept & first prototype
First drawing to working device in one month, tested across ferrous substrates.
-
Engineering partnership & IP
CAD design and prototype iteration with Merge Medical Device Studio; US provisional patent application filed; funding support from Foundation Venture Capital Group.
-
Prototype finalization
Hematoma system in design finalization with successful use on multiple clinic patients; ear plug system in initial prototyping.
-
FDA Class I registration
Estimated ~$30K and ~1 month for a Class I device.
-
Manufacturing & launch
Tooling, production, and go-to-market through provider and direct-to-consumer channels: the phase this raise funds.
What we're seeking
Three ways to work with EarArmor
Co-development & licensing
Medical device companies interested in developing, licensing, or acquiring the moldable magnet technology.
Commercial expertise
Manufacturing, distribution, and consumer medical device operators who have taken Class I products to market.
The pitch deck
The full presentation
Technology, market analysis, SWOT, regulatory strategy, and the plan. The same deck we present in person.
Download PDF
01 / 32
Open PDF ↗
Start the conversation
Talk to the founder directly
Reach Dr. Solomon and the EarArmor team through the contact page, or email directly. Every serious inquiry gets a reply.